abstract |
The invention relates to compounds of formula (I), or a salt thereof wherein R 1 , A, L, and R 2 and n are as described herein. Compounds of formula (I) and pharmaceutical compositions thereof are ανβ1 integrin inhibitors that are useful for treating tissue specific fibrosis. |